|
MAPK9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.124600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.523360E-01 |
| Normal-vs-Stage2 |
2.037400E-01 |
| Normal-vs-Stage3 |
6.587600E-01 |
| Normal-vs-Stage4 |
8.095800E-01 |
| Stage1-vs-Stage2 |
6.077800E-01 |
| Stage1-vs-Stage3 |
5.494500E-02 |
| Stage1-vs-Stage4 |
1.330800E-01 |
| Stage2-vs-Stage3 |
9.592000E-02 |
| Stage2-vs-Stage4 |
1.551790E-01 |
| Stage3-vs-Stage4 |
8.762000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.409600E-01 |
| Normal-vs-AfricanAmerican |
3.370200E-02 |
| Normal-vs-Asian |
7.822600E-01 |
| Caucasian-vs-AfricanAmerican |
5.580500E-04 |
| Caucasian-vs-Asian |
9.086200E-01 |
| AfricanAmerican-vs-Asian |
2.050000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.117200E-01 |
| Normal-vs-Female |
1.699230E-01 |
| Male-vs-Female |
1.936230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.309800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.227800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.283800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.207400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.333970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.719630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.015840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.574200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.822600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.457000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.233600E-01 |
| Normal-vs-Grade 2 |
9.394000E-02 |
| Normal-vs-Grade 3 |
5.929600E-01 |
| Normal-vs-Grade 4 |
2.548400E-01 |
| Grade 1-vs-Grade 2 |
8.765600E-01 |
| Grade 1-vs-Grade 3 |
7.543000E-01 |
| Grade 1-vs-Grade 4 |
2.548800E-01 |
| Grade 2-vs-Grade 3 |
1.898360E-01 |
| Grade 2-vs-Grade 4 |
6.420300E-03 |
| Grade 3-vs-Grade 4 |
9.735600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.603310E-03 |
| Normal-vs-ccB subtype |
7.382000E-01 |
| ccA subtype-vs-ccB subtype |
1.649570E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.459600E-01 |
| Normal-vs-N1 |
7.065200E-01 |
| N0-vs-N1 |
3.537400E-01 |
|
|
